Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human NR1D1 aa 550 to the C-terminus (Cysteine residue). The exact sequence is proprietary.
Database link: P20393
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab174309 in the following tested applications.
|ICC/IF||1/100 - 1/250.|
|IHC-P||1/50 - 1/100.|
|WB||1/1000 - 1/5000. Predicted molecular weight: 67 kDa.|
Immunohistochemical analysis of paraffin-embedded human uterus tissue labeling NR1D1 with ab174309 at 1/50 dilution.
Immunofluorescent analysis of HeLa cells labeling NR1D1 with ab174309 at 1/100 dilution.
Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labeling NR1D1 with ab174309 at 1/20 dilution(10ug/mL) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488)(1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) was used as the unlabeled control.
Immunohistochemical analysis of paraffin-embedded human colon carcinoma tissue labeling NR1D1 with ab174309 at 1/50 dilution.